Quantifying Intracellular Viral Pathogen: Specimen Preparation, Visualization and Quantification of Multiple Immunofluorescent Signals in Fixed Human Airway Epithelium Cultured at Air-Liquid Interface.

SARS-CoV-2 air-liquid interface airway infection cystic fibrosis quantification tiled imaging wholemount immunofluorescence

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
07 Oct 2022
Historique:
received: 29 07 2022
revised: 29 09 2022
accepted: 04 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Infection control and aggressive antibiotic therapy play an important role in the management of airway infections in individuals with cystic fibrosis (CF). The responses of airway epithelial cells to pathogens are likely to contribute to the pathobiology of CF lung disease. Primary airway epithelial cells obtained from individuals with CF, cultured and differentiated at air-liquid interface (ALI), effectively mimic the structure and function of the in vivo airway epithelium. With the recent respiratory viral pandemics, ALI cultures were extensively used to model respiratory infections in vitro to facilitate physiologically relevant respiratory research. Immunofluorescence staining and imaging were used as an effective tool to provide a fundamental understanding of host-pathogen interactions and for exploring the therapeutic potential of novel or repurposed drugs. Therefore, we described an optimized quantitative fluorescence microscopy assay for the wholemount staining and imaging of epithelial cell markers to identify distinct cell populations and pathogen-specific targets in ALI cultures of human airway epithelial cells grown on permeable support insert membranes. We present a detailed methodology using a graphical user interface (GUI) package to quantify the detected signals on a tiled whole membrane. Our method provided an imaging strategy of the entire membrane, overcoming the common issue of undersampling and enabling unbiased quantitative analysis.

Identifiants

pubmed: 36294807
pii: jpm12101668
doi: 10.3390/jpm12101668
pmc: PMC9605096
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Australian National Health and Medical Research Council grant
ID : NHMRC_APP1188987
Organisme : Rebecca L. Cooper Foundation project grant
Organisme : Cystic Fibrosis Australia-The David Millar Giles Innovation Grant
Organisme : Sydney Children Hospital Network Foundation grant
Organisme : Luminesce Alliance Research grant

Références

J Biol Chem. 2015 Oct 30;290(44):26404-11
pubmed: 26354429
J Histochem Cytochem. 2001 Dec;49(12):1565-72
pubmed: 11724904
Biol Proced Online. 2018 Feb 01;20:3
pubmed: 29434527
J Histochem Cytochem. 2014 Apr 10;62(6):405-423
pubmed: 24722432
Cells. 2022 Apr 15;11(8):
pubmed: 35456026
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997283
Cell Rep. 2021 May 4;35(5):109055
pubmed: 33905739
Nat Commun. 2020 Aug 6;11(1):3910
pubmed: 32764693
J Pathol. 1997 Sep;183(1):116-23
pubmed: 9370957
J Fluoresc. 2020 Dec;30(6):1483-1489
pubmed: 32870453
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2119680119
pubmed: 35353667
mBio. 2022 Jan 18;:e0343621
pubmed: 35038898
F1000Res. 2017 Jun 8;6:851
pubmed: 28713558
Cell Commun Signal. 2021 May 27;19(1):63
pubmed: 34044844
EMBO J. 2021 Mar 1;40(5):e105912
pubmed: 33283287
Int J Mol Sci. 2022 Jan 13;23(2):
pubmed: 35055020
Methods Mol Biol. 2019;1897:299-311
pubmed: 30539454
Am J Physiol Lung Cell Mol Physiol. 2011 Jan;300(1):L25-31
pubmed: 20971803
Am J Respir Cell Mol Biol. 2011 Apr;44(4):465-73
pubmed: 20525805
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Mol Biol Cell. 2016 Jan 15;27(2):219-22
pubmed: 26768859
Front Immunol. 2018 Dec 20;9:3067
pubmed: 30619379
Am J Respir Cell Mol Biol. 2017 May;56(5):568-574
pubmed: 27983869
J Virol. 2013 Jun;87(11):6081-90
pubmed: 23427150
Eur J Histochem. 2007 Jan-Mar;51(1):59-66
pubmed: 17548270
Cell Rep. 2014 Aug 21;8(4):1198-209
pubmed: 25131206
Am J Respir Cell Mol Biol. 2022 Jul;67(1):99-111
pubmed: 35471184
J Vis Exp. 2021 Nov 10;(177):
pubmed: 34842237
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1056-L1062
pubmed: 32233789
Bio Protoc. 2018 Jun 5;8(11):
pubmed: 30009215
mBio. 2021 Jan 12;12(1):
pubmed: 33436426
J Cyst Fibros. 2021 Mar;20(2):364-371
pubmed: 33414087
Am J Physiol. 1995 Mar;268(3 Pt 1):L347-60
pubmed: 7900815
Int J Mol Sci. 2022 Jan 26;23(3):
pubmed: 35163349
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):
pubmed: 33811184

Auteurs

Sharon L Wong (SL)

School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Molecular and Integrative Cystic Fibrosis Research Centre (miCF_RC), University of New South Wales, Sydney, NSW 2052, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.

Elvis Pandzic (E)

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW 2052, Australia.

Egi Kardia (E)

School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Molecular and Integrative Cystic Fibrosis Research Centre (miCF_RC), University of New South Wales, Sydney, NSW 2052, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.

Katelin M Allan (KM)

School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Molecular and Integrative Cystic Fibrosis Research Centre (miCF_RC), University of New South Wales, Sydney, NSW 2052, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.

Renee M Whan (RM)

School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW 2052, Australia.

Shafagh A Waters (SA)

School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Molecular and Integrative Cystic Fibrosis Research Centre (miCF_RC), University of New South Wales, Sydney, NSW 2052, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Department of Respiratory Medicine, Sydney Children's Hospital, Randwick, NSW 2031, Australia.

Classifications MeSH